02 December 2002
Ann Transplant 2002; 7(4): 15-15 :: ID: 496257
Relationships between academic medical institutions as well as individual physicians have been vigorously debated in media and within the medical society during last years. Recently, European Federation of Internal Medicine, the ACP-ASIM Foundation, and the ABIM Foundation have developed a “physician’s charter” a sort of contemporary Hippocrates’s oath, to encompass a set of principles to which all medical professionals can and should aspire (1).
Keywords: Organ Transplantation, pharmaceutical industry, Clinical Trials
Most Viewed Current Articles
26 Jan 2022 : Review articleRecurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
Ann Transplant 2022; 27:e934924
24 Aug 2021 : Review articleNormothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588